171 related articles for article (PubMed ID: 20679509)
1. Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.
Hajdu S; Holinka J; Reichmann S; Hirschl AM; Graninger W; Presterl E
Antimicrob Agents Chemother; 2010 Oct; 54(10):4078-84. PubMed ID: 20679509
[TBL] [Abstract][Full Text] [Related]
2. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Presterl E; Hajdu S; Lassnigg AM; Hirschl AM; Holinka J; Graninger W
Antimicrob Agents Chemother; 2009 Aug; 53(8):3205-10. PubMed ID: 19451280
[TBL] [Abstract][Full Text] [Related]
3. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Hajdu S; Lassnigg A; Graninger W; Hirschl AM; Presterl E
J Orthop Res; 2009 Oct; 27(10):1361-5. PubMed ID: 19396814
[TBL] [Abstract][Full Text] [Related]
4. Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
Ozturk B; Gunay N; Ertugrul BM; Sakarya S
Can J Microbiol; 2016 Sep; 62(9):735-43. PubMed ID: 27295353
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
6. ANTI-ADHESIVE AND ANTI-BIOFILM ACTIVITIES IN VITRO OF LINEZOLID, VANCOMYCIN, TIGECYCLINE AND DAPTOMYCIN AGAINST STAPHYLOCOCCUS HAEMOLYTICUS.
Juda M; Helon P; Malm A
Acta Pol Pharm; 2016 Nov; 73(6):1539-1543. PubMed ID: 29634108
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
8. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.
Niska JA; Shahbazian JH; Ramos RI; Pribaz JR; Billi F; Francis KP; Miller LS
Antimicrob Agents Chemother; 2012 May; 56(5):2590-7. PubMed ID: 22371896
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
Aslan H; Yapar N
Mikrobiyol Bul; 2015 Oct; 49(4):475-83. PubMed ID: 26649405
[TBL] [Abstract][Full Text] [Related]
12. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
[TBL] [Abstract][Full Text] [Related]
14. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
15. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
17. Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.
LaPlante KL; Rybak MJ
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):125-30. PubMed ID: 15474322
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.
Petersen PJ; Bradford PA; Weiss WJ; Murphy TM; Sum PE; Projan SJ
Antimicrob Agents Chemother; 2002 Aug; 46(8):2595-601. PubMed ID: 12121938
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
Tang HJ; Chen CC; Cheng KC; Toh HS; Su BA; Chiang SR; Ko WC; Chuang YC
J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Stuart JI; John MA; Milburn S; Diagre D; Wilson B; Hussain Z
Int J Antimicrob Agents; 2011 Mar; 37(3):248-52. PubMed ID: 21295951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]